Company / CapEx per Share
ENDRA Life Sciences Inc. CapEx per Share History
FY2017-FY2020 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest CapEx per Share
$0.01
FY2020
5-year range
$0.00 / $0.01
FY2017-FY2020
Trend
-33.6%
vs FY2019
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $0.00 to $0.01 over the past 2 years.
Based on SEC 10-K filings.
0.01 in FY2020 with a 3-year CAGR of -6.3%.
Improved from $0.00 to $0.01 over the past 2 years.
CapEx per Share over time
Growth rates
- 3-Year CAGR
- -6.3%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2020, capex per share decreased 33.6% year-over-year.
Company context
Key Data Points
- Altman Z-Score -7.14 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | CapEx per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2020 | $0.01 | -33.6% |
| FY2019 | $0.01 | +572.2% |
| FY2018 | $0.00 | -81.6% |
| FY2017 | $0.01 | - |
As of FY2020 · SEC 10-K · Updated Jun 28, 2026